Exodus Point Capital Management, LP Pulse Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 21,864 shares of PLSE stock, worth $314,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,864Holding current value
$314,841% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLSE
# of Institutions
87Shares Held
5.76MCall Options Held
29.4KPut Options Held
24K-
Black Rock Inc. New York, NY1.15MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.11MShares$16 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC805KShares$11.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA469KShares$6.76 Million0.0% of portfolio
-
State Street Corp Boston, MA422KShares$6.08 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $535M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...